|
시장보고서
상품코드
1339177
니파바이러스 검사 시장, 점유율, 규모, 동향 및 산업 분석 보고서 : 표본별, 제품 유형별, 최종 사용자별, 지역별, 부문별 예측(2023-2032년)Nipah Virus Testing Market Share, Size, Trends, Industry Analysis Report, By Sample (Blood, Throat & Nasal Swab, Urine, and Others); By Product Type; By End-User; By Region; Segment Forecast, 2023 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 니파바이러스 검사 시장 규모는 2032년까지 30억 3,668만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
새로운 첨단 혈액검사 도입이 급증하고 있으며, 진단용 면역측정 시약 및 키트에 대한 지속적인 수요 증가와 기술적으로 혁신적인 진단기술의 보급이 결합되어 시장 수요와 성장을 가속하고 있습니다. 여러 바이러스를 동시에 검출할 수 있는 멀티플렉스 검사 플랫폼 시장 개척은 니파바이러스의 신속하고 정확한 진단에도 중요하며, 시장 성장에 긍정적으로 기여할 가능성이 높습니다.
예를 들어, 2023년 4월, Molbio Diagnostics는 H3N2와 H1N1 바이러스를 위해 개발된 새로운 Truenat 테스트를 발표했습니다.
세계 연구자들이 니파바이러스 RNA를 검출할 수 있는 역전사 중합효소 연쇄반응 분석법을 빠르게 개발하여 민감하고 특이적이며 저농도에서도 바이러스를 검출할 수 있게 됨에 따라 시장 성장 잠재력이 크게 확대되고 있습니다. 이 외에도 주로 과거 또는 현재 감염을 발견하기 위해 혈청 학적 분석의 사용에 대한 보급이 급증하고 있으며, 이는 감시 및 역학 연구에 유용하기 때문에 가까운 미래에 시장을 촉진할 가능성이 높습니다.
또한, AI와 ML 알고리즘의 통합은 최근 몇 년동안 니파 바이러스 유전체 정보의 대규모 데이터 세트 분석을 지원하기 위해 큰 견인차 역할을 하고 있습니다. 이러한 도구는 특히 연구자들이 바이러스의 주요 유전자 마커를 식별하기 위해 널리 사용되고 있으며, 더 나은 진단 테스트와 치료법을 개발하는 데 도움이 될 수 있습니다.
니파바이러스 검사 시장 보고서 하이라이트
높은 신뢰성과 높은 바이러스 검출 정확도로 인해 혈액 샘플이 널리 사용되고 있습니다.
ELISA 키트 부문이 가장 큰 시장 점유율을 차지했는데, 이는 주로 여러 유형의 질병 마커를 관리하고 항원을 정량적으로 측정하는 데 사용되었기 때문입니다.
호스피탈리티 부문이 2022년 세계 시장에서 큰 비중을 차지했는데, 이는 주로 세계 병원에서 이러한 검사를 이용할 수 있도록 하기 위한 지출이 증가했기 때문으로 분석됩니다.
아태지역은 정부 및 민간 의료기관의 투자 증가와 지역 전체에서 이러한 검사 서비스 이용에 중점을 두고 있어 조사 기간 동안 가장 빠른 성장률을 보일 것으로 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 니파바이러스 검사 시장에 관한 인사이트
- 니파바이러스 검사 시장 - 최종사용자 현황
- 니파바이러스 검사 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 니파바이러스 검사 시장 최종사용자 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 니파바이러스 검사 시장, 샘플별
- 주요 조사 결과
- 서론
- 혈액
- 목과 코 면봉
- 뇨
- 기타
제6장 세계의 니파바이러스 검사 시장, 제품 유형별
- 주요 조사 결과
- 서론
- ELISA 키트
- RT PCR 기반 키트
제7장 세계의 니파바이러스 검사 시장, 최종사용자별
- 주요 조사 결과
- 서론
- 병원
- 진단센터
- 연구실
- 기타
제8장 세계의 니파바이러스 검사 시장, 지역별
- 주요 조사 결과
- 서론
- 니파바이러스 검사 시장 평가, 지역별, 2019-2032년
- 니파바이러스 검사 시장 - 북미
- 북미 : 니파바이러스 검사 시장, 샘플별, 2019-2032년
- 북미 : 니파바이러스 검사 시장, 최종사용자별, 2019-2032년
- 북미 : 니파바이러스 검사 시장, 제품 유형별, 2019-2032년
- 니파바이러스 검사 시장 - 미국
- 니파바이러스 검사 시장 - 캐나다
- 니파바이러스 검사 시장 - 유럽
- 유럽 : 니파바이러스 검사 시장, 샘플별, 2019-2032년
- 유럽 : 니파바이러스 검사 시장, 최종사용자별, 2019-2032년
- 유럽 : 니파바이러스 검사 시장, 제품 유형별, 2019-2032년
- 니파바이러스 검사 시장 - 영국
- 니파바이러스 검사 시장 - 프랑스
- 니파바이러스 검사 시장 - 독일
- 니파바이러스 검사 시장 - 이탈리아
- 니파바이러스 검사 시장 - 스페인
- 니파바이러스 검사 시장 - 네덜란드
- 니파바이러스 검사 시장 - 러시아
- 니파바이러스 검사 시장 - 아시아태평양
- 아시아태평양 : 니파바이러스 검사 시장, 샘플별, 2019-2032년
- 아시아태평양 : 니파바이러스 검사 시장, 최종사용자별, 2019-2032년
- 아시아태평양 : 니파바이러스 검사 시장, 제품 유형별, 2019-2032년
- 니파바이러스 검사 시장 - 중국
- 니파바이러스 검사 시장 - 인도
- 니파바이러스 검사 시장 - 말레이시아
- 니파바이러스 검사 시장 - 일본
- 니파바이러스 검사 시장 - 인도네시아
- 니파바이러스 검사 시장 - 한국
- 니파바이러스 검사 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 니파바이러스 검사 시장, 샘플별, 2019-2032년
- 중동 및 아프리카 : 니파바이러스 검사 시장, 최종사용자별, 2019-2032년
- 중동 및 아프리카 : 니파바이러스 검사 시장, 제품 유형별, 2019-2032년
- 니파바이러스 검사 시장 - 사우디아라비아
- 니파바이러스 검사 시장 - 아랍에미리트(UAE)
- 니파바이러스 검사 시장 - 이스라엘
- 니파바이러스 검사 시장 - 남아프리카
- 니파바이러스 검사 시장 - 라틴아메리카
- 라틴아메리카 : 니파바이러스 검사 시장, 샘플별, 2019-2032년
- 라틴아메리카 : 니파바이러스 검사 시장, 최종사용자별, 2019-2032년
- 라틴아메리카 : 니파바이러스 검사 시장, 제품 유형별, 2019-2032년
- 니파바이러스 검사 시장 - 멕시코
- 니파바이러스 검사 시장 - 브라질
- 니파바이러스 검사 시장 - 아르헨티나
제9장 경쟁 구도
- 확장 및 인수 분석
- 확장
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Lupin
- Starlake Bioscience
- MyBioSource
- Krishgen Biosystems
- Roche Diagnostics
- Aurobindo
- Novartis
- Bio-Rad Laboratories
- Xaretto
- Liferiver
- Merck
- Vivacure
- Minapharm
- Creative Diagnostics
- Luminex Corporation
- Quidel Corporation
- Roche
- Abbexa
- GenMark Diagnostics
- Seegene
- Hologic
The global nipah virus testing market size is expected to reach USD 3,036.68 million by 2032, according to a new study by Polaris Market Research. The report "Nipah Virus Testing Market Share, Size, Trends, Industry Analysis Report, By Sample (Blood, Throat & Nasal Swab, Urine, and Others); By Product Type; By End-User; By Region; Segment Forecast, 2019 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing proliferation towards introducing several new and more advanced point-of-care blood tests and continuously growing demand for immunoassay reagents & kits for the diagnosis purpose coupled with the widespread availability of technologically innovated diagnostic techniques, has been propelling the demand and growth of the market. Growing development of multiplex testing platforms that can detect multiple viruses simultaneously which also could be important for rapid and accurate diagnosis of Nipah virus, is likely to contribute positively towards the market growth.
For instance, in April 2023, Molbio Diagnostics, announced the launch of its new Truenat test, maily developed for H3N2 and H1N1 virus, that is approved by Central Drugs Standard Control Organization and could also provide sample-to-result in just an hour's time.
The rapid development of reverse transcription polymerase chain reaction assays by researchers across the globe, that can detect Nipah virus RNA which are highly sensitive and specific, and could detect the virus even in low concentrations is creating huge growth potential for the market. Beside this, surging penetration regarding the use serological assays mainly to discover past or current infections, which can be useful for surveillance and epidemiological studies is likely to foster the market in the near future.
Furthermore, growing integration of AI and ML algorithms in order to help analyze large datasets of Nipah virus genomic information is gaining significant traction in the recent years. These tools are also being widely used by researchers specially to identify key genetic markers of the virus, which could inform the development of better diagnostic tests and treatments.
Nipah Virus Testing Market Report Highlights
Blood segment held the maximum market revenue share in 2022, on account of widespread use of the sample due to its high reliability and provide better accuracy of virus detection
ELISA Kits segment accounted for largest market share, mainly due to increased usage to manage several types of disease markers and also allow the quantitative measurements for the antigens
Hospitals segment dominated the global market with substantial share in 2022, which is mainly driven increased expenditure on making these tests available in hospitals across the globe
Asia Pacific region is anticipated to grow at fastest growth rate over the study period, owing to growing investment by both government and private healthcare institutions and focus on availing these testing services across the region
The global key market players include: Roche Diagnostics, Starlake Bioscience, Novartis, Creative Diagnostics, Roche, GenMark Diagnostics, and Merck
Polaris Market Research has segmented the Nipah virus testing market report based on sample, product, end-user, and region:
Nipah Virus Testing, Sample Outlook (Revenue - USD Million, 2019 - 2032)
- Blood
- Throat & Nasal Swab
- Urine
- Others
Nipah Virus Testing, Product Type Outlook (Revenue - USD Million, 2019 - 2032)
- ELISA Kits
- RT PCR-based Kits
Nipah Virus Testing, End-User Outlook (Revenue - USD Million, 2019 - 2032)
- Hospitals
- Diagnostic Centers
- Research Centers
- Research Labs
- Others
Nipah Virus Testing, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data End-Users
- 3.2.1. Primary End-Users
- 3.2.2. Secondary End-Users
4. Global Nipah Virus Testing Market Insights
- 4.1. Nipah Virus Testing Market - End-User Snapshot
- 4.2. Nipah Virus Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising investment in research and development
- 4.2.1.2. Growing incorporation of artificial intelligence and machine learning algorithms
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of awareness
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Nipah Virus Testing Market End-User Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Nipah Virus Testing Market, by Sample
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 5.3. Blood
- 5.3.1. Global Nipah Virus Testing Market, by Blood, by Region, 2019-2032 (USD Million)
- 5.4. Throat & Nasal Swab
- 5.4.1. Global Nipah Virus Testing Market, by Throat & Nasal Swab, by Region, 2019-2032 (USD Million)
- 5.5. Urine
- 5.5.1. Global Nipah Virus Testing Market, by Urine, by Region, 2019-2032 (USD Million)
- 5.6. Others
- 5.6.1. Global Nipah Virus Testing Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Nipah Virus Testing Market, by Product Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 6.3. ELISA Kits
- 6.3.1. Global Nipah Virus Testing Market, by ELISA Kits, by Region, 2019-2032 (USD Million)
- 6.4. RT PCR-based Kits
- 6.4.1. Global Nipah Virus Testing Market, by RT PCR-based Kits, by Region, 2019-2032 (USD Million)
7. Global Nipah Virus Testing Market, by End-User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 7.3. Hospitals
- 7.3.1. Global Nipah Virus Testing Market, by Hospitals, By Region, 2019-2032 (USD Million)
- 7.4. Diagnostic Centers
- 7.4.1. Global Nipah Virus Testing Market, by Diagnostic Centers, By Region, 2019-2032 (USD Million)
- 7.5. Research Labs
- 7.5.1. Global Nipah Virus Testing Market, by Research Labs, By Region, 2019-2032 (USD Million)
- 7.6. Others
- 7.6.1. Global Nipah Virus Testing Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Nipah Virus Testing Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Nipah Virus Testing Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Nipah Virus Testing Market - North America
- 8.3.1. North America: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.3.2. North America: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.3.3. North America: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.3.4. Nipah Virus Testing Market - U.S.
- 8.3.4.1. U.S.: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.3.5. Nipah Virus Testing Market - Canada
- 8.3.5.1. Canada: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.4. Nipah Virus Testing Market - Europe
- 8.4.1. Europe: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.4.2. Europe.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.4.3. Europe: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.4.4. Nipah Virus Testing Market - UK
- 8.4.4.1. UK: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.4.4.3. UK: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.4.5. Nipah Virus Testing Market - France
- 8.4.5.1. France: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.4.5.2. France.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.4.5.3. France: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.4.6. Nipah Virus Testing Market - Germany
- 8.4.6.1. Germany: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.4.7. Nipah Virus Testing Market - Italy
- 8.4.7.1. Italy: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.4.8. Nipah Virus Testing Market - Spain
- 8.4.8.1. Spain: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.4.9. Nipah Virus Testing Market - Netherlands
- 8.4.9.1. Netherlands: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.4.10. Nipah Virus Testing Market - Russia
- 8.4.10.1. Russia: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.5. Nipah Virus Testing Market - Asia Pacific
- 8.5.1. Asia Pacific: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.5.4. Nipah Virus Testing Market - China
- 8.5.4.1. China: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.5.4.2. China.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.5.4.3. China: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.5.5. Nipah Virus Testing Market - India
- 8.5.5.1. India: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.5.5.2. India.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.5.5.3. India: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.5.6. Nipah Virus Testing Market - Malaysia
- 8.5.6.1. Malaysia: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.5.7. Nipah Virus Testing Market - Japan
- 8.5.7.1. Japan: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.5.8. Nipah Virus Testing Market - Indonesia
- 8.5.8.1. Indonesia: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.5.9. Nipah Virus Testing Market - South Korea
- 8.5.9.1. South Korea: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.6. Nipah Virus Testing Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.6.4. Nipah Virus Testing Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.6.5. Nipah Virus Testing Market - UAE
- 8.6.5.1. UAE: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.6.6. Nipah Virus Testing Market - Israel
- 8.6.6.1. Israel: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.6.7. Nipah Virus Testing Market - South Africa
- 8.6.7.1. South Africa: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.7. Nipah Virus Testing Market - Latin America
- 8.7.1. Latin America: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.7.3. Latin America: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.7.4. Nipah Virus Testing Market - Mexico
- 8.7.4.1. Mexico: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.7.5. Nipah Virus Testing Market - Brazil
- 8.7.5.1. Brazil: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
- 8.7.6. Nipah Virus Testing Market - Argentina
- 8.7.6.1. Argentina: Nipah Virus Testing Market, by Sample, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Nipah Virus Testing Market, by End-User, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Nipah Virus Testing Market, by Product Type, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Lupin
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Starlake Bioscience
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. MyBioSource
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Krishgen Biosystems
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Roche Diagnostics
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Aurobindo
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Novartis
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Bio-Rad Laboratories
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Xaretto
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Liferiver
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Merck
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Vivacure
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Minapharm
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Creative Diagnostics
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Luminex Corporation
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. Quidel Corporation
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. Roche
- 10.17.1. Company Overview
- 10.17.2. Financial Performance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development
- 10.18. Abbexa
- 10.18.1. Company Overview
- 10.18.2. Financial Performance
- 10.18.3. Product Benchmarking
- 10.18.4. Recent Development
??????? 10.19. GenMark Diagnostics
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.20. Seegene
- 10.20.1. Company Overview
- 10.20.2. Financial Performance
- 10.20.3. Product Benchmarking
- 10.20.4. Recent Development
??????? 10.21. Hologic
- 10.21.1. Company Overview
- 10.21.2. Financial Performance
- 10.21.3. Product Benchmarking
- 10.21.4. Recent Development
